Global Program Head at Sandoz Biopharmaceuticals, Basel, Switzerland; overseeing end to end development of biosimilars starting from early R&D, clinical development through commercialization. A physician by training and has about 15 years of experience in clinical development covering innovative medicines and biosimilars.